Young Nigerians Recording BP as High as 230/100mmHg, Medical Expert Blames Misinformation, Drug Access

A medical expert has raised alarm over rising cases of hypertension among young Nigerian adults, disclosing that some patients have recorded blood pressure readings as high as 230/100mmHg, figures she described as alarmingly high for people still in the prime of their working lives.

Dr Joy Audu, a volunteer with Pro-Health International, said several of the patients diagnosed with dangerously elevated blood pressure were in their 30s and 40s, an age range in which the condition has traditionally been considered less common but is now increasingly showing up in her clinical experience.

Audu attributed the growing challenge to a combination of ignorance, misinformation, poor access to prescribed medicines, and continued reliance on unqualified practitioners, particularly within rural communities where formal healthcare access remains limited. She explained that some patients who had already been diagnosed with hypertension and placed on medication by qualified doctors went on to discontinue treatment after being told, often by people within their own communities, that blood pressure drugs should not be taken on a daily basis, a piece of misinformation she said has directly undermined treatment adherence among affected patients.

Beyond medication discontinuation driven by community misinformation, Audu said some patients outright rejected their medical diagnoses despite recording clearly elevated blood pressure readings. She noted that some individuals dismissed their condition on religious grounds, believing prayer or faith alone should resolve the issue, while others rejected the diagnosis simply because they had no known family history of hypertension, mistakenly assuming this ruled out the possibility of developing the condition themselves.

Explaining the broader clinical picture, Audu noted that hypertension can stem from a range of contributing factors, including family history, genetic predisposition, and environmental influences. She warned that prolonged, untreated hypertension carries serious long-term health risks, including damage to eyesight and kidney function, as well as erectile dysfunction in men, complications that often develop gradually and may not become apparent to patients until the condition has caused significant, sometimes irreversible, harm.

Beyond misinformation and denial, Audu identified poor access to prescribed medicines as another major structural challenge undermining hypertension management in Nigeria. She explained that some patients, despite being financially able to afford their prescribed medication, are simply unable to locate the drugs within their own communities, a supply gap that leaves them vulnerable to unqualified practitioners offering alternative remedies without adequate medical knowledge of the patient's underlying condition or how such alternatives might interact with it.

Given these compounding challenges, misinformation, denial, and inconsistent drug availability, Audu stressed the need for sustained health education efforts, particularly targeted at rural communities where awareness gaps and access barriers tend to be most pronounced. She argued that improving public understanding of hypertension, its risk factors, and the importance of consistent treatment adherence remains essential to reversing the troubling patterns she has observed among younger patients.

Audu's warning adds to a growing body of concern among Nigerian health experts regarding the country's rising hypertension burden. Nationally, hypertension prevalence has climbed sharply in recent decades, with estimates showing the condition affecting a significant proportion of Nigerian adults, a trend health authorities and researchers have variously linked to lifestyle changes, socioeconomic pressures, and gaps in primary healthcare access and drug availability, particularly across rural parts of the country. Experts have separately noted that treatment adherence challenges, including the specific forms of misinformation Audu highlighted around medication discontinuation, remain a persistent barrier to effective hypertension control even where patients have already been correctly diagnosed and started on treatment.

For health authorities and advocacy groups working to address Nigeria's hypertension burden, Audu's account underscores a recurring theme: that improving clinical diagnosis and treatment access alone may not be sufficient without parallel, sustained efforts to counter the community-level misinformation that continues to derail patients already under medical care.